Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.
about
Use of antineoplastic agents in patients with cancer who have HIV/AIDS.Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management.The in vivo response of novel buprenorphine metabolites, M1 and M3, to antiretroviral inducers and inhibitors of buprenorphine metabolism.
P2860
Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Interaction of delavirdine wit ...... f CYP2C9, CYP2C19, and CYP2D6.
@ast
Interaction of delavirdine wit ...... f CYP2C9, CYP2C19, and CYP2D6.
@en
type
label
Interaction of delavirdine wit ...... f CYP2C9, CYP2C19, and CYP2D6.
@ast
Interaction of delavirdine wit ...... f CYP2C9, CYP2C19, and CYP2D6.
@en
prefLabel
Interaction of delavirdine wit ...... f CYP2C9, CYP2C19, and CYP2D6.
@ast
Interaction of delavirdine wit ...... f CYP2C9, CYP2C19, and CYP2D6.
@en
P2093
P1476
Interaction of delavirdine wit ...... of CYP2C9, CYP2C19, and CYP2D6
@en
P2093
L C Wienkers
P E Sanders
R L Voorman
P577
2001-01-01T00:00:00Z